Abbott Laboratories (ABT)
131.50
-1.55
(-1.16%)
USD |
NYSE |
May 22, 16:00
131.47
-0.03
(-0.02%)
After-Hours: 20:00
Abbott Laboratories Cash from Investing (Quarterly): -470.00M for March 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp | -500.00M |
| Stryker Corp | -4.136B |
| Intuitive Surgical Inc | 213.50M |
| Baxter International Inc | 3.265B |
| Becton Dickinson & Co | -192.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.417B |
| Cash from Financing (Quarterly) | -2.055B |
| Free Cash Flow | 6.657B |
| Free Cash Flow Per Share (Quarterly) | 0.534 |
| Free Cash Flow to Equity (Quarterly) | 1.816B |
| Free Cash Flow to Firm (Quarterly) | 969.52M |
| Free Cash Flow Yield | 2.90% |